Navigation Links
Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
Date:7/21/2010

CRANBURY, N.J., July 21 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today that the Company's Chairman and CEO, John F. Crowley, testified on behalf of the Biotechnology Industry Organization (BIO) at the Senate Committee on Health, Education, Labor and Pensions bipartisan, full committee hearing focused on rare and neglected diseases held on Wednesday, July 21 on Capitol Hill. Mr. Crowley, a member of the Board of Directors of BIO, provided background and perspectives on the current state of drug development for orphan products. He also made a series of recommendations to the Committee regarding the establishment of additional incentives for companies to develop more treatments for rare and neglected diseases.

During his testimony, Mr. Crowley discussed the unprecedented success of the Orphan Drug Act (ODA) of 1983 and its market-based incentives for biotechnology and pharmaceutical companies to develop products for rare diseases. Crowley made several recommendations on new policies for the Committee's consideration to accelerate the development of treatments for rare and neglected diseases that will complement and advance the objectives of the ODA and facilitate the availability of the next generation of orphan products for children.  

These recommendations included:

  • Improving the U.S. Food and Drug Administration (FDA) regulatory environment for pediatric rare diseases;
  • Establishing a separate Division of Genetic and Metabolic Disorders at FDA;
  • Urging FDA to publish further guidance regarding increased use of surrogate endpoints for pro
    '/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
2. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
3. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
4. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
5. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
6. Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
8. Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
9. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
10. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
11. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Calif. , Oct. 31, 2014 ThynkWare ... sclerosis (ALS) patients initiate text and email messages using ... a patent-pending technology invented by ThynkWare,s founder, Duane ... on a smartphone device. This technology allows users to ... only the power of thought. ThynkWare provides ...
(Date:10/31/2014)... Migranade, Inc. announced today the new migraine ... 36 million U.S. migraine sufferers November, 2014. The medicine ... actual cause of migraines and not just the symptoms. ... source Migranade is assured to be a game changer ... available at http://www.migranade.com and will soon hit ...
(Date:10/31/2014)... NORTH CHICAGO, Ill., Oct. 31, 2014  AbbVie ... results for the third quarter ended Sept. 30, ... the strong performance of our business with double-digit ... Our underlying business grew nearly 14 percent in ... chairman and chief executive officer, AbbVie.  "We exceeded ...
Breaking Medicine Technology:ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Game Changing Migraine Medication To Be Available November 2014 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
... Texas, Oct. 4, 2011 Today, Children,s ... in the state and the only stand-alone facility between Dallas ... Earlier, hospital personnel used Scott & White,s state-of-the-art Simulation Center ... Hospital, which was housed in Scott & White Hospital-Temple, before ...
... OTCQX: RHHBY) announced plans today to expand its coagulation testing ... clinics with the development of a full line of coagulation ... expected to be introduced in the U.S. and Canada in ... Roche Diagnostics is the global market leader in coagulation ...
Cached Medicine Technology:Children's Hospital at Scott & White Opens 2Children's Hospital at Scott & White Opens 3Children's Hospital at Scott & White Opens 4Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2
(Date:10/31/2014)... The process of cell division is central to life. ... each other, has fascinated scientists since the dawn of ... long, it has been notoriously difficult to study this ... before cleaving in two. , The name given to ... "cell movement" and captures the sense of a highly ...
(Date:10/31/2014)... The Prevention Research Center for Healthy Neighborhoods (PRCHN) ... is a key player in nearly $13.32 million ... in Northeast Ohio. , The Centers for Disease ... for $4.35 million over five years. The funds ... testing, and disseminating individual, environmental, and policy interventions ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Daily Gossip writes ... is actually described as the fastest fat loss program ever ... less than a month. , There is no wonder after ... eBook of all time. The new nutrition and workout fat ... and fitness expert. , According to the author of ...
(Date:10/31/2014)... October 31, 2014 At the start ... families narrowly escaping carbon monoxide poisoning in their homes. ... weeks away, one family-owned, Missouri-based heating and cooling company ... making sure families start the home heating season with ... secure. , Beginning Nov. 1, 2014, E and ...
(Date:10/31/2014)... Tampa, FL (PRWEB) October 31, 2014 ... Infrared-Active compression gear. The new gear is now available ... information on the benefits of Celliant infrared-active athletic gear ... recently reported that another contract has been signed for ... Olympic speedskaters for the next eight years. In light ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4
... treatment, radiation may be a better choice than ... cancer, //according to a randomized controlled trial published ... The authors suggest that a combination of chemotherapy ... for these patients. ,Approximately 80 percent of ...
... finds that survivors of acute lymphoblastic leukemia have a ... the general population. // ,Acute lymphoblastic leukemia is ... almost 4,000 new cases diagnosed in the United States ... curable pediatric cancers: survival rates for patients who receive ...
... a weekly treatment with a nasal spray of virus enzymes ... based on results of a study. Such a treatment would ... avoiding the problem of antibiotic resistance. ,Middle ear ... the middle ear space that can cause pain, fever, irritability, ...
... the state government on a public suit demanding// protection ... litigation (PIL), filed by an NGO, Health, Environment and ... to be protected from silicosis, which is rife due ... malpractice of the mine owners. ,"We had ...
... Pitt donated $100,000 of their money to help// construct the ... ,They made the donation to the Duk Lost Boys Clinic ... in the spring and serve more than 150,000 people. ... of the "lost boys" of Sudan who is the director ...
... urged governments to join the anti-tuberculosis global plan, which ... the disease has become extremely drug-resistant. ,Ban's ... Day on Saturday. The World Health Organization (WHO) recently ... strain of tuberculosis, XDR-TB, which threatens to derail efforts ...
Cached Medicine News:Health News:Radiation Preferred Over Surgery for Patients With Some Stages of Lung Cancer 2Health News:Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 3Health News:Public Interest Litigation Filed Favoring Mineworkers Against Silicosis 2
... protection to the exposed airway of the tracheostomy ... it ideal for active young children as well ... and moisture recovery, it ensures patient comfort and ... have ISO standard tapered ends to assure a ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
Medicine Products: